Personal Injury Law

Defective Drugs and Lawsuits

By Owen, Patterson & Owen

Medications such as Celebrex, Bextra, and Vioxx have been linked to an increased risk of blood clots, heart attacks and strokes. It is estimated that between 7,000 and 9,000 Celebrex and Bextra cases have been filed by people who claim the defective painkillers caused heart attacks and strokes. According to The Wall Street Journal, firms have been offered $40,000 to $50,000 a client to resolve Celebrex cases and as much as $200,000 a client for Bextra. Despite the drugs apparent risk, Celebrex continued to generate $2.3 billion in sales in 2007, a 12 percent increase from the previous year. According to a report in Friday?s Wall Street Journal, lawyers representing Pfizer have indicated the company is willing to pay as much as $500 million to resolve all outstanding cases.

Full post as published by Personal Injury Attorneys--Owen, Patterson & Owen on May 09, 2008 (boomark / email).